Genomic Valley Biotech Market Cap ($1.60M USD)

Market Cap ₹14.40 Cr $1.60M USD As of November 2026

Genomic Valley Biotech Market Cap ($1.60M USD). As of Nov. 19, 2026, Genomic Valley Biotech (GVBL) market capitalisation is ₹14.40 Cr ($1.60M), with 30.68 L shares outstanding at a current price of ₹46.93 on BSE, ranking 4666 out of 5368 companies by market cap in our screener. Genomic Valley Biotech operates in the Healthcare sector and is classified as a Small Cap stock. For live price, earnings and the complete company profile, see GVBL stock price BSE.

Current Price
₹46.93
Outstanding Shares
30.68 L
Market Cap Rank
#4666
Top Percentile
13.1%

Market Cap History of Genomic Valley Biotech (Last 10 Years)

GVBL market capitalisation from year-end BSE closing prices over the last 10 years. Review GVBL earnings multiple to evaluate earnings-based valuation against sector peers.

End of Year Market Cap History — Genomic Valley Biotech

GVBL year-end market cap in INR and USD with closing share price and annual change — BSE closing prices.

Year Market Cap Share Price Exchange Change
2026
₹14.40 Cr $1.60M USD
₹46.93 BSE +89.92%
2025
₹7.58 Cr $842,446 USD
₹24.71 BSE -69.09%
2024
₹24.53 Cr $2.73M USD
₹79.95 BSE +113.54%
2023
₹11.49 Cr $1.28M USD
₹37.44 BSE +55.68%
2022
₹7.38 Cr $819,945 USD
₹24.05 BSE +6.89%
2021
₹6.90 Cr $767,100 USD
₹22.50 BSE -
2020
₹6.90 Cr $767,100 USD
₹22.50 BSE -

Market Cap Data Sources

Tickjournal (INR) ₹14.40 Cr
Tickjournal (USD) $1.60M
Price Source BSE
USD to INR Rate ₹90.00